Acquiring Company
RPC
Acquired Company
Angelini Pharma
Atlanta
RomeEnergyOil And GasBiotechnologyHealth CarePharmaceuticalDescription
RPC has successfully acquired the Peracidin® product line from Angelini Pharma. This acquisition enhances RPC's portfolio of high-quality sterilants for various applications. The move aligns with RPC's commitment to providing exceptional service and reliable supply to its customers. RPC aims to leverage the Peracidin® brand's legacy to strengthen its market presence further.
Don't miss RPC's next move
Get an email the moment RPC makes an acquisition, hires an exec, or expands, usually minutes after it happens.
One email per event. Unsubscribe anytime.
Related People
M&A Insights
Based on deal dataFrequently asked
Who acquired Angelini Pharma?
Angelini Pharma was acquired by RPC, based in Atlanta. The deal was reported on August 24, 2026. RPC is publicly traded (RES) and operates in Energy.
When did RPC acquire Angelini Pharma?
RPC's acquisition of Angelini Pharma was reported on August 24, 2026. RPC has successfully acquired the Peracidin® product line from Angelini Pharma. This acquisition enhances RPC's portfolio of high-quality sterilants for various applications. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Angelini Pharma do?
Angelini Pharma is part of the privately owned Angelini Industries and is an emerging leader in brain health. It is privately held, operating in Biotechnology, and is based in Rome.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick. $29 a month, billed annually, and if it does not pay for itself in a year we refund it.